CV Sciences (CVSI) Cash from Investing Activities Growth (5y) (2018 - 2026)
CV Sciences (CVSI) Cash from Investing Activities Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.92 Bn | 42.96 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.19 Bn | 39.53 Bn | 2.15 Bn |
| 3 | Zoetis | 31.74 Bn | 30.06 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.67 Bn | 22.87 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.22 Bn | 19.56 Bn | 683.80 Mn |
| 6 | Viatris | 18.71 Bn | 17.83 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.55 Bn | 15.16 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.80 Bn | 11.27 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - |
| 10 | CV Sciences | 4.10 Mn | 3.84 Mn | 1.45 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.82% |
| Dec 31, 2025 | 49.08% |
| Sep 30, 2025 | 47.95% |
| Jun 30, 2025 | -13.51% |
| Mar 31, 2025 | 39.16% |
| Dec 31, 2024 | 38.30% |
| Sep 30, 2024 | 15.84% |
| Jun 30, 2024 | 38.37% |
| Dec 31, 2023 | 28.23% |
| Dec 31, 2020 | -21.38% |
| Sep 30, 2020 | 33.52% |
| Jun 30, 2020 | -19.39% |
| Mar 31, 2020 | -309.22% |
| Dec 31, 2019 | 27.50% |
| Sep 30, 2019 | -45.23% |
| Jun 30, 2019 | -27.57% |
| Mar 31, 2019 | -27.89% |
| Dec 31, 2018 | -45.55% |
| Sep 30, 2018 | 22.64% |
| Jun 30, 2018 | 41.78% |